146 related articles for article (PubMed ID: 18019378)
1. Mutations of the noggin and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP).
Lucotte G; Lagarde JP;
Genet Couns; 2007; 18(3):349-52. PubMed ID: 18019378
[No Abstract] [Full Text] [Related]
2. Mutations of the noggin (NOG) and of the activin A type I receptor (ACVR1) genes in a series of twenty-seven French fibrodysplasia ossificans progressiva (FOP) patients.
Lucotte G; Houzet A; Hubans C; Lagarde JP; Lenoir G
Genet Couns; 2009; 20(1):53-62. PubMed ID: 19400542
[TBL] [Abstract][Full Text] [Related]
3. Mutational screening of ACVR1 gene in Brazilian fibrodysplasia ossificans progressiva patients.
Carvalho DR; Navarro MM; Martins BJ; Coelho KE; Mello WD; Takata RI; Speck-Martins CE
Clin Genet; 2010 Feb; 77(2):171-6. PubMed ID: 19796185
[TBL] [Abstract][Full Text] [Related]
4. Response to "Mutations of the NOGGIN and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP)" by Lucotte et al.
Kaplan FS; Xu M; Feldman G; Brown M; Cho TJ; Choi IH; Connor JM; Delai PL; Economides AN; Glaser DL; Groppe J; Katagiri T; Le Merrer M; Morhart R; Ravazzolo R; Rogers JG; Smith R; Triffitt JT; Urtizberea JA; Zasloff M; Shore EM
Genet Couns; 2008; 19(3):357-9; author reply 361-3. PubMed ID: 18990993
[No Abstract] [Full Text] [Related]
5. The tale of FOP, NOGGIN and myristoylation: no data, no proof!
Seemann P; Mundlos S
Genet Couns; 2008; 19(3):353-5; author reply 361-3. PubMed ID: 18990992
[No Abstract] [Full Text] [Related]
6. A new mutation of the noggin gene in a French Fibrodysplasia ossificans progressiva (FOP) family.
Fontaine K; Sémonin O; Legarde JP; Lenoir G; Lucotte G
Genet Couns; 2005; 16(2):149-54. PubMed ID: 16080294
[TBL] [Abstract][Full Text] [Related]
7. Genetic abnormalities in fibrodysplasia ossificans progressiva.
Miao J; Zhang C; Wu S; Peng Z; Tania M
Genes Genet Syst; 2012; 87(4):213-9. PubMed ID: 23229308
[TBL] [Abstract][Full Text] [Related]
8. Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva.
Takahashi M; Katagiri T; Furuya H; Hohjoh H
Gene Ther; 2012 Jul; 19(7):781-5. PubMed ID: 22130450
[TBL] [Abstract][Full Text] [Related]
9. [Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].
Katagiri T; Kamizono J; Nakashima Y; Kitoh H; Susami T; Haga N
Clin Calcium; 2010 Oct; 20(10):1510-7. PubMed ID: 20890033
[TBL] [Abstract][Full Text] [Related]
10. ACVR1 gene mutations in four Turkish patients diagnosed as fibrodysplasia ossificans progressiva.
Eresen Yazıcıoğlu C; Karatosun V; Kızıldağ S; Ozsoylu D; Kavukçu S
Gene; 2013 Feb; 515(2):444-6. PubMed ID: 23260810
[TBL] [Abstract][Full Text] [Related]
11. Localization of the gene for fibrodysplasia ossificans progressiva (FOP) to chromosome 17q21-22.
Lucotte G; Bathelier C; Mercier G; Gérard N; Lenoir G; Sémonin O; Fontaine K;
Genet Couns; 2000; 11(4):329-34. PubMed ID: 11140409
[TBL] [Abstract][Full Text] [Related]
12. [Genetic basis for skeletal disease. Establishment of novel treatments for fibrodysplasia ossificans progressiva (FOP)].
Katagiri T
Clin Calcium; 2010 Aug; 20(8):1204-11. PubMed ID: 20675931
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H.
Ohte S; Shin M; Sasanuma H; Yoneyama K; Akita M; Ikebuchi K; Jimi E; Maruki Y; Matsuoka M; Namba A; Tomoda H; Okazaki Y; Ohtake A; Oda H; Owan I; Yoda T; Furuya H; Kamizono J; Kitoh H; Nakashima Y; Susami T; Haga N; Komori T; Katagiri T
Biochem Biophys Res Commun; 2011 Apr; 407(1):213-8. PubMed ID: 21377447
[TBL] [Abstract][Full Text] [Related]
14. Fibrodysplasia ossificans progressiva as a form of pseudodystonia.
Dulski J; Sławek J
Parkinsonism Relat Disord; 2020 Aug; 77():180-181. PubMed ID: 32046912
[TBL] [Abstract][Full Text] [Related]
15. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.
Shore EM; Xu M; Feldman GJ; Fenstermacher DA; Cho TJ; Choi IH; Connor JM; Delai P; Glaser DL; LeMerrer M; Morhart R; Rogers JG; Smith R; Triffitt JT; Urtizberea JA; Zasloff M; Brown MA; Kaplan FS
Nat Genet; 2006 May; 38(5):525-7. PubMed ID: 16642017
[TBL] [Abstract][Full Text] [Related]
16. Muscle imaging in fibrodysplasia ossificans progressiva: The neurologist's perspective.
Tasca G; D'Amico A; Verardo M; Villani A; Siani P; De Brasi D; Bertini E; Boldrini R
Neuromuscul Disord; 2015 Aug; 25(8):672-3. PubMed ID: 26077615
[No Abstract] [Full Text] [Related]
17. De novo 617G-A nucleotide mutation in the ACVR1 gene in a Taiwanese patient with fibrodysplasia ossificans progressiva.
Lin GT; Chang HW; Liu CS; Huang PJ; Wang HC; Cheng YM
J Hum Genet; 2006; 51(12):1083-1086. PubMed ID: 17077940
[TBL] [Abstract][Full Text] [Related]
18. Significant difference of opinion regarding the role of noggin in fibrodysplasia ossificans progressiva.
Warman ML
Am J Med Genet; 2002 Apr; 109(2):162; author reply 163-4. PubMed ID: 11977169
[No Abstract] [Full Text] [Related]
19. Bone morphogenetic proteins with some comments on fibrodysplasia ossificans progressiva and NOGGIN.
Cohen MM
Am J Med Genet; 2002 Apr; 109(2):87-92. PubMed ID: 11977155
[No Abstract] [Full Text] [Related]
20. Characterization of bone morphogenetic protein 4 receptor in fibrodysplasia ossificans progressiva.
Lanchoney TF; Olmsted EA; Shore EM; Gannon FA; Rosen V; Zasloff MA; Kaplan FS
Clin Orthop Relat Res; 1998 Jan; (346):38-45. PubMed ID: 9577408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
